Adma Biologics | ADMA - Current Liabilities


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Adma Biologics

Adma Biologics reported $36.73M in Current Liabilities for its fiscal quarter ending in March of 2023.


Current Liabilities Change
Adamis Pharmaceuticals ADMP:US USD 12.95M 1.55M
Adma Biologics ADMA:US USD 36.73M 2.54M
Agile Therapeutics AGRX:US USD 18.51M 5.12M
Alnylam Pharmaceuticals ALNY:US USD 673.39M 94.52M
Dynavax Technologies DVAX:US USD 91.52M 58.56M
Minerva Neurosciences NERV:US USD 2.5M 1.12M
Novavax NVAX:US USD 1.92B 541.09M
Takeda 4502:JP JPY 2.48T 245.13B